Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2-59 Months of Age, Mongolia, 2015-2021.

Authors:
von Mollendorf C; Ulziibayar M; Nguyen CD; Batsaikhan P; Suuri B and 10 more

Journal:
Emerg Infect Dis

Publication Year: 2024

DOI:
10.3201/eid3003.230864

PMCID:
PMC10902538

PMID:
38407131

Journal Information

Journal Title: Emerg Infect Dis

Detailed journal information not available.

Publication Details

Subject Category: Infectious Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"C.v.M., M.U., C.D.N, P.B., B.S., D.L., C.S., T.M., and E.K.M. are investigators on a Pfizer collaborative research project outside this work. E.M.D. is employed by Pfizer. C.S., E.K.M., and C.D.N. are investigators on a Merck Investigator Studies Program grant funded by MSD outside this work. The other authors have no relevant conflicts of interest to declare."

Evidence found in paper:

"We acknowledge the Ministry of Health in Mongolia, the WHO country and regional offices, and colleagues at UNICEF for their support for this project; Stephen Lacey for his assistance with the review of radiologic equipment and training of radiology staff in Mongolia; and the study staff, laboratory staff in Mongolia and Murdoch Children’s Research Institute, and participating families. This project was funded by the Gavi Alliance (contract no. PP61690717A2). C.S. was supported by a National Health and Medical Research Council Career Development Fellowship (1087957) and a veski inspiring women fellowship. Authors affiliated with Murdoch Children’s Research Institute were supported by the Victoria government Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. C.v.M., M.U., C.D.N, P.B., B.S., D.L., C.S., T.M., and E.K.M. are investigators on a Pfizer collaborative research project outside this work. E.M.D. is employed by Pfizer. C.S., E.K.M., and C.D.N. are investigators on a Merck Investigator Studies Program grant funded by MSD outside this work. The other authors have no relevant conflicts of interest to declare."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025